The neurodegenerative condition currently affects around 153,000 people in the UK Parkinson’s UK has awarded nearly £100,000 to researchers at Imperial College London (ICL) to […]
Therapy shows high efficacy in initial trial phase AC Immune SA has reported encouraging interim results from its phase 2 VacSYn clinical trial of ACI-7104.056, […]
How the emc supports the accessibility of medicines information Distributing reliable information about medicines is challenging for the pharma industry and the healthcare professionals (HCPs) […]